<DOC>
	<DOCNO>NCT00297219</DOCNO>
	<brief_summary>The high rate cardiovascular complication dialysis population explain traditional cardiovascular risk factor . One factor propose contribute cardiovascular mortality dialysis patient population vascular calcification possibly result disturbance calcium-phosphate metabolism . The aim study assess effect treatment dialysate contain 1.75 1.5 mmol/L 1.25 mmol/L calcium regard coronary artery calcification bone histomorphometry hemodialysis patient .</brief_summary>
	<brief_title>Effects Lowering Dialysate Calcium Level Progression Coronary Artery Calcification Bone Histomorphometry</brief_title>
	<detailed_description>Sample size calculation base previously report change coronary artery calcification score hemodialysis patient time ( 90 % power two-sided , alpha error rate 5 % ) . Four hundred fifty-seven hemodialysis patient , take drop-out rate consideration , enrol prospective-controlled study.The case already treat calcium-based phosphate binder dialysate contain 1.75 1.5 mmol/L calcium enrol eight hemodialysis centers.The case randomize two arm : 1 . Dialysate contain 1.25 mmol/L calcium + calcium-based phosphate binder group : Dialysate calcium reduce 1.75 1.5 mmol/L 1.25 mmol/L group . Patients use calcium-based phosphate binder accord phosphate level . 2 . Dialysate contain 1.75 mmol/L calcium + calcium-based phosphate binder group ( Control group ) : Dialysate calcium remain switched 1.75 mmol/L patient calcium-based phosphate binder . The study last 18 months.Coronary artery calcification ( Multi-slice CT ) , bone histomorphometry , bone mineral density assess begin end study . Coronary artery calcification bone mineral density measure patient ; bone histomorphometry assess 150 patient , 75 group .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>Aged 18 80 year On maintenance bicarbonate hemodialysis schedule thrice weekly , least 12 hours/week To treat dialysate contain 1.75 1.5 mmol/L calcium Willingness participate study write informed consent To schedule living donor renal transplantation To serious lifelimiting comorbid situation , namely active malignancy , active infection , endstage cardiac , pulmonary , hepatic disease Pregnancy lactate To unable give inform consent mental incompetence psychiatric disorder To vitamin D treatment within six month randomization iPTH value target level ( &gt; 300 pg/mL ) Hypercalcemia ( Ca &gt; 10.5 mg/dl ) use dialysate contain 1.75 1.5 mmol/L calcium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>Coronary artery calcification</keyword>
	<keyword>Adynamic bone disease</keyword>
	<keyword>Dialysate calcium</keyword>
	<keyword>Bone mineral density</keyword>
	<keyword>Bone histomorphometry</keyword>
</DOC>